Uttam Yashwant Patil
Vermogen: 102 123 $ op 31-05-2026
Vermogen: 102 123 $ op 31-05-2026
Uttam Yashwant Patil currently works at AiBtl BioPharma, Inc., as Co-Chief Executive Officer from 2025, ABVC BioPharma, Inc., as Chief Executive & Financial Officer from 2023, Biokey, Inc., as Chief Operating & Scientific Officer from 2023, and Rgene Corp., as Manager-Research & Development from 2023.
Dr. Patil received his doctorate degree from National Tsing-Hua University and undergraduate degree and graduate degree from the University of Pune.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ABVC BIOPHARMA, INC. 0,28% | 27-02-2026 | 72.428 ( 0,28% ) | 102 123 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ABVC BIOPHARMA, INC. | Algemeen Directeur | 23-06-2023 |
Biokey, Inc.
Biokey, Inc. Pharmaceuticals: GenericHealth Technology Develops and markets generic drugs | Operationeel Directeur | 01-05-2023 |
Rgene Corp.
Rgene Corp. Financial ConglomeratesFinance Operates as an investment holding company | Hoofd Techniek/Wetenschap/O&O | 01-05-2023 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
National Tsing-Hua University
National Tsing-Hua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pune
University of Pune Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ABVC BioPharma, Inc.
ABVC BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company which develops drugs and medical devices in the fields of oncology, ophthalmology and central nervous system | Health Technology |
Biokey, Inc.
Biokey, Inc. Pharmaceuticals: GenericHealth Technology Develops and markets generic drugs | Health Technology |
Rgene Corp.
Rgene Corp. Financial ConglomeratesFinance Operates as an investment holding company | Finance |
Kies jouw editie
Alle financiële informatie op nationaal niveau